EuropaWire10h
Pfizer and BioNTech’s Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive EU Opinion, Awaiting Approval
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...
Maintaining Buy Rating on Apellis Pharmaceuticals Amid European Setback and US Market Focus
Bank of America Securities analyst Tazeen Ahmad has maintained their bullish stance on APLS stock, giving a Buy rating yesterday. Tazeen Ahmad ...
Apellis Pharmaceuticals Hold Rating Justified Amidst EU Setbacks and Market Challenges
Analyst Derek Archila of Wells Fargo assigned a Hold rating on Apellis Pharmaceuticals (APLS – Research Report), retaining the price ...
pharmaphorum21h
Digital innovation drives vaccine development
The importance of innovation The COVID-19 vaccines were brought to market faster than any other vaccines in history. At Pfizer and BioNTech, this was accomplished by creating cross-functional ...